| HOME >> BIOLOGY >> TECHNOLOGY |
Protein-protein interaction as basis for drug target identification172
Protein-PCNA interaction as basis for drug design172
Two-hybrid protein interaction technology for target identification173
Biosensors for detection of small molecule-protein interactions173
Protein-protein interaction maps174
ProNet (Myriad Genetics)174
Hybrigenics' maps of protein-protein interactions174
CellZome's functional map of protein-protein interactions175
Mapping of protein-protein interactions by mass spectrometry175
Protein interaction map of Drosophila melanogaster176
Protein-interaction map of Wellcome Trust Sanger Institute176
Protein-protein interactions as targets for therapeutic intervention176
Inhibition of protein-protein interactions by peptide aptamers177
Selective disruption of proteins by small molecules177
Post-genomic combinatorial biology approach177
Differential proteomics178
Shotgun proteomics178
Chemogenomics/chemoproteomics for drug discovery179
Chemoproteomics-based drug discovery180
Companies involved in chemogenomics/chemoproteomics181
Activity-based proteomics182
Locus Discovery technology182
Automated ligand identification system183
Expression proteomics: protein level quantification183
Role of phage antibody libraries in target discovery184
Analysis of posttranslational modification of proteins by MS184
Phosphoproteomics for drug discovery185
Application of glycoproteomics for drug discovery185
Role of carbohydrates in proteomics185
Challenges of glycoproteomics186
Companies involved in glycoproteomics186
Role of protein microarrays/ biochips for drug discovery187
Protein microarrays vs DNA microarrays for high-throughput screening187
BIA-MS biochip for protein-prote
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |